1Yong G, Khairy P, De Guise P, et al. Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study. Circ Cardiovasc Interv, 2009,2 : 455-462.
2Balint OH, Samman A, Haberer K, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart,2008,94:1189-1193.
2Masura J, Walsh KP, Thanopoulous B, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol, 1998,31:878-882.
3Krichenko A, Benson LN, Burrows P, et al. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol,1989,63:877-880.
4Bush A, Busset C, Knight WB, et al. Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy,Ann Rev Res Pir Des,1987,136:767-769.
5ThanoPoulos BD,Tsaousis GS,Djukic M,et al.Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder Hert,2002,87:260-263.
